Abstract: Objective Curcumin is a plant polyphenolic compound and a major component of spice turmeric (Curcuma longa). It has been reported to possess free radical-scavenging, iron-chelating, and anti-inflammatory properties in different tissues. Our previous study showed that curcumin protects MES23.5 dopaminergic cells from 6-hydroxydopamine (6-OHDA)-induced neurotoxicity in vitro. The present study aimed to explore this neuroprotective effect in the 6-OHDAlesioned rat model of Parkinson's disease in vivo. Methods Rats were given intragastric curcumin for 24 days. 6-OHDA lesioning was conducted on day 4 of curcumin treatment. Dopamine content was assessed by high-performance liquid chromatography with electrochemical detection, tyrosine hydroxylase (TH)-containing neurons by immunohistochemistry, and iron-containing cells by Perls' iron staining. Results The dopamine content in the striatum and the number of THimmunoreactive neurons decreased after 6-OHDA treatment. Curcumin pretreatment reversed these changes. Further studies demonstrated that 6-OHDA treatment increased the number of iron-staining cells, which was dramatically decreased by curcumin pretreatment. Conclusion The protective effects of curcumin against 6-OHDA may be attributable to the ironchelating activity of curcumin to suppress the iron-induced degeneration of nigral dopaminergic neurons.
Introduction
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the selective loss of dopaminergic neurons in the substantia nigra (SN), resulting in a clinical syndrome characterized by stiffness, tremor, slowness of movement, and postural instability. However, the etiology of PD has yet to be fully uncovered. Increasing evidence suggests that iron plays a key role. Iron catalyzes the formation of highly toxic free radicals through the Fenton reaction, resulting in impaired mitochondrial function and autoactivity of proteases and phospholipases, leading to cell death [1] . Increased iron levels have been found in the SN of PD patients, as well as in 6-hydroxydopamine (6-OHDA)-induced animal models of PD [2] [3] [4] [5] [6] . Recently, antioxidant and iron-chelating strategies have been the focuses of PD treatment [7, 8] , among which flavonoids are considered to be the most promising candidates because of their well-reported biological properties.
Flavonoids are plant polyphenolic compounds that can protect against oxidative stress by scavenging free radicals [9] and chelating iron [10] . The polyphenolic flavonoid curcumin (1,7-bis[4-hydroxy 3-methoxy phenyl]-1,6-heptadiene-3,5-dione) ( Fig. 1 ) from Curcuma longa exhibits 254 anti-inflammatory [11] , antioxidant [12] , and iron-chelating activities [13] . It was reported that curcumin attenuates the incidence of colon cancer and is anti-atherogenic, and these effects are associated with its antioxidant activity [11] .
Curcumin has cytoprotective effects against MPP + neurotoxicity in PC12 cells via its anti-apoptotic and antioxidant properties through the Bcl-2-mitochondrion-reactive oxygen species-inducible nitric oxide synthase pathway [14] .
Our previous work has also demonstrated that curcumin attenuates 6-OHDA-induced cytotoxicity by anti-oxidation and nuclear factor kappa B modulation in MES23.5 cells [15] , which suggests that curcumin has a neuroprotective effect on dopaminergic neurons in PD.
6-OHDA is a neurotoxin commonly used to produce PD models. Previous studies have shown that iron content is increased in the SN of 6-OHDA-induced PD models [2, 16, 17] , while iron chelators are neuroprotective against PD. Curcumin is known to have this iron-chelating activity in vitro [18] [19] [20] . However, whether it has neuroprotective effects on dopaminergic neurons in PD animal models through iron-chelating activity remains unknown. Therefore, the present study aimed to investigate the effects of curcumin on the degeneration of dopaminergic neurons and on iron levels in the SN of 6-OHDA-treated rats. injection, the microinjection needle was left in place for a further 5 min before being slowly extracted [16] . Control animals received injections of saline containing 0.2 mg/mL
Materials and methods

Materials
L-ascorbate.
The rats were divided into three groups: (1) 
High-performance liquid chromatography with electrochemical detection
The rats were anesthetized with chloral hydrate (400 mg/kg, i.p.) and then decapitated. Both sides of the striatum were carefully isolated and transferred into liquid nitrogen for storage. Samples were prepared as previously described [22] . Separation was 
TH immunohistochemical staining of SN Immuno-
histochemistry was performed as previously described [22] .
Briefly, the sections were warmed to room temperature, due to the relative sparseness of such cells [16] . All counts were carried out by an experimenter unaware of the animal groups. Immunocytochemical staining was analyzed as for the TH staining above. One section was chosen from every three sections throughout the SNpc per brain.
Perls' iron staining
Data analysis
All experiments were done in triplicate. Data are expressed as mean ± SEM, and analyzed using one-way analysis of variance followed by the StudentNewman-Keuls test. P <0.05 was considered statistically significant.
Results
Curcumin protected against 6-OHDA-induced depletion of dopamine and its metabolites in the rat
striatum Twenty-one days after 6-OHDA lesioning, the levels of dopamine and its metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) decreased on the lesioned side of the striatum, while curcumin partly restored the levels (Fig. 2) . The homovanillic acid (HVA) level was, however, unchanged. In addition, no changes were found on the contralateral side of the striatum in each group (data not shown).
Curcumin protected against 6-OHDA-induced decrease of TH-positive neurons in rat SN
The TH-positive neurons in the normal SN were multipolar, with darkly stained somata and dendrites (Fig. 3A, D) . On day 21 after 6-OHDA lesioning, the TH-positive neurons markedly decreased on the lesioned side (Fig. 3 B, E, G), but were significantly restored by curcumin pretreatment (Fig. 3 C, F, G). However, in the SN on the unlesioned side, both the morphology and the number of TH-positive neurons remained unchanged (data not shown). (Fig. 4) . Besides, no significant difference was found in the SN on the unlesioned side in each group (data not shown).
Curcumin inhibited
Discussion
Curcumin has been shown to possess anti-inflammatory [11] , powerful antioxidant [12] , iron-chelating [13] and free radical-scavenging [9] properties. The present study reported the neuroprotective activity of curcumin in a 6-OHDAinduced model of PD. We showed that curcumin pretreatment reversed the 6-OHDA-induced decrease in the levels of dopamine and its metabolite DOPAC in the striatum, indicating that curcumin could restore the dopamine content.
However, the HVA level did not change in the 6-OHDA treatment group compared with the sham control group.
This might be due to compensation by the dopamine system under conditions of dopamine depletion. The released dopamine increased its metabolism into HVA, thereby increasing the HVA content.
6-OHDA injures dopaminergic neurons both in vivo
and in vitro by three main mechanisms: reactive oxygen species, hydrogen peroxide formation, and direct inhibition of the mitochondrial respiratory chain [23] . 6-OHDA- shown that the iron-containing cell types in the SN are glia and neurons [16, 23, 24] . In addition, iron chelators protect dopaminergic neurons against PD by eliminating excess iron [25] . These findings suggest that the iron-chelating activity of curcumin plays an important role in its protective effects on dopaminergic neurons. In fact, several studies have
shown that curcumin binds iron [13, 20] with an affinity similar to other iron chelators such as nitrilotriacetic acid [20] . Proton donation from the phenolic group is responsible for the "superb antioxidant" properties of curcumin [19] .
In conclusion, the present data showed that curcumin 
